Arterial stiffness as a cardiovascular events risk marker and possibilities for its downregulation by contemporary antihypertensive medications

Cover Page

Cite item

Full Text

Abstract

Arterial blood pressure measured by Korotkov’s method is a non-valid predictor for possible cardiovascular events, which requires introduction of new methods of arterial hypertension diagnostics. Recently, the effect on arterial stiffness has become a very important characteristic of antihypertensive drugs overall efficacy. Evaluation of arterial stiffness (central aortic pressure, augmentation index and pulse wave velocity) contributes to more precise cardiovascular risk stratification and reflects target organ damage and the effectiveness of antihypertensive treatment. In particular, pulse wave velocity exceeding 12 m/s is a significant risk factor of cardiovascular events. Arterial compliance can be determined by applanation tonometry, pulse wave shift at the carotid and femoral arteries, finger photoplethysmography, volume pulsoxymetry, echo-tracking, suprasystolic pulse waves recording method and cardio-ankle vascular index. Different effects of antihypertensive drugs on arterial stiffness at the same blood pressure reduction have been repeatedly shown. The article discusses the impact of the most commonly used antihypertensive drugs, including contemporary antihypertensive drugs combinations, on arterial stiffness. Effect of beta-blockers greatly varies depending on the characteristics of the drug, diuretics have neutral effect, calcium antagonists (especially amlodipine) decrease the pulse wave speed and arterial wall stiffness. Both angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers (more data for enalapril, perindopril and valsartan) were effective in decreasing arterial wall stiffness. A significant reduction in arterial wall stiffness was mainly found if antihypertensive drugs combinations were used, especially the combination of calcium antagonists and angiotensin-converting enzyme inhibitors/angiotensin receptor blockers.

About the authors

N Sh Zagidullin

Bashkir State Medical University, Ufa, Russia

Email: znaufal@mail.ru

R Kh Zulkarneev

Bashkir State Medical University, Ufa, Russia

E S Scherbakova

Bashkir State Medical University, Ufa, Russia

Yu F Safina

Bashkir State Medical University, Ufa, Russia

Sh Z Zagidullin

Bashkir State Medical University, Ufa, Russia

References

  1. Олейников В.Э., Матросова И.Б., Томашевская Ю.А и др. Влияние терапии метопрололом на артериальную ригидность // Рационал. фармакотерап. в кардиол. - 2011. - №7 (6). - С. 685-689.
  2. Allemann Y., Fraile B., Lambert M. et al. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study // J. Clin. Hypertens. (Greenwich). - 2008. - Vol. 10, N 3. - P. 185-194.
  3. Aronow W.S., Fleg J.L., Pepine C.J. et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents // J. Am. Coll. Cardiol. - 2011. - Vol. 57. - P. 2037-2114.
  4. Asmar R., Topouchian J., Pannier B. et al. Pulse wave velocity as endpoint in large-scale intervention trial. The COMPLIOR study // J. Hypertens. - 2001. - Vol. 19. - P. 813-818.
  5. Asmar R.G., London G.M., O’Rourke M.E. et al. REASON Project Coordinators and Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol // Hypertension. - 2001. - Vol. 38. - P. 922-926.
  6. Avolio A.P., Van Bortel L.M., Boutouyrie P. et al. Role of pulse pressure amplification in arterial hypertension: experts’ opinion and review of the data // Hypertension. - 2009. - Vol. 54. - P. 375-383.
  7. Blacher J., Protogerou A.D., Safar M.E. Large artery stiffness and antihypertensive agents // Curr. Pharm. Des. - 2005. - Vol. 11. - P. 3317-3326.
  8. Boutouyrie P., Lacolley P., Briet M. et al. Pharmacological modulation of arterial stiffness // Drugs. - 2011. - Vol. 71. - P. 1689-1701.
  9. Chobanian A.V., Bakris G.L., Black H.R. et al.; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure // Hypertension. - 2003. - Vol. 42. - P. 1206-1252.
  10. Dahlöf B., Sever P.S., Poulter N.R. et al.; ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial // Lancet. - 2005. - Vol. 366. - P. 895-906.
  11. Deary A.J., Schumann A.L., Murfet H. et al. Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs // J. Hypertens. - 2002. - Vol. 20. - Р. 771-777.
  12. Dhakam Z., McEniery C.M., Yasmin A. et al. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity // Am. J. Hypertens. - 2006. - Vol. 19. - P. 214-219.
  13. Glasser S.P., Arnett D.K., McVeigh G.E. et al. The importance of arterial compliance in cardiovascular drug therapy // J. Clin. Pharmacol. - 1998. - Vol. 38. - P. 202-212.
  14. Hayoz D., Zappe D.H., Meyer M.A. et al. Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen // Clin. Hypertens. (Greenwich). - 2012. - Vol. 14, N 11. - P. 773-778.
  15. Hirata K., Vlachopoulos C., Adji A. et al. Benefits from angiotensin-converting enzyme inhibitor «beyond blood pressure lowering»: beyond blood pressure or beyond the brachial artery? // J. Hypertens. - 2005. - Vol. 23. - P. 551-556.
  16. Jiang X.J., O’Rourke M.F., Zhang Y.Q. et al. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure // J. Hypertens. - 2007. - Vol. 25. - P. 1095-1099.
  17. Kaiser E., Klebs S., Lied T. et al. A database analysis to evaluate the risk of cardiovascular events inhypertensive patients being treated with either the single pill combination of valsartan and amlodipine or respective free combinations // J. Hypertens. - 2011. - Vol. 29. - P. 15 434.
  18. Kampus P., Serg M., Kals J. et al. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness // Hypertension. - 2011. - Vol. 57. - P. 1122-1128.
  19. Laurent S., Briet M., Boutouyrie P. Large and small artery cross-talk and recent morbidity-mortality trials in hypertension // Hypertension. - 2009. - Vol. 54. - P. 388-392.
  20. Laurent S., Cockcroft J., Van Bortel L. et al.; European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications // Eur. Heart J. - 2006. - Vol. 27. - P. 2588-2605.
  21. London G.M., Pannier B., Guerin A.P. et al. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade // Circulation. - 1994. - Vol. 90. - P. 2786-2796.
  22. Mahmud A., Feely J. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension // J. Hum. Hypertens. - 2000. - Vol. 14. - Р. 541-546.
  23. Mancia G., De Backer G., Dominiczak A. et al. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) // J. Hypertens. - 2007. - Vol. 25. - P. 1105-1187.
  24. Mattace-Raso F.U., van der Cammen T.J., Hofman A. et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study // Circulation. - 2006. - Vol. 113. - P. 657-663.
  25. Mitchell G.F., Hwang S.J., Vasan R.S. et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study // Circulation. - 2010. - Vol. 121. - P. 505-511.
  26. Morgan T., Lauri J., Bertram D. et al. Effect of different antihypertensive drug classes on central aortic pressure // Am. J. Hypertens. - 2004. - Vol. 17. - P. 118-123.
  27. Najjar S.S., Scuteri A., Shetty V. et al. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging // J. Am. Coll. Cardiol. - 2008. - Vol. 51. - P. 1377-1383.
  28. Nakamura T., Fujii S., Hoshino J. et al. Selective angiotensin receptor antagonism with valsartan decreases arterial stiffness independently of blood pressure lowering in hypertensive patients // Hypertens. Res. - 2005. - Vol. 28, N 12. - P. 937-943.
  29. Pini R., Cavallini M.C., Palmieri V. et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study // J. Am. Coll. Cardiol. - 2008. - Vol. 51. - P. 2432-2439.
  30. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies // Lancet. - 2002. - Vol. 360. - P. 1903-1913.
  31. Protogerou A., Blacher J., Stergiou G.S. et al. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study // J. Am. Coll. Cardiol. - 2009. - Vol. 53. - P. 445-451.
  32. Protogerou A.D., Stergiou G.S., Vlachopoulos C. et al. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: evidence for specific class-effects of antihypertensive drugs on pressure amplification // Curr. Pharm. Des. - 2009. - Vol. 15. - P. 272-289.
  33. Roman M.J., Devereux R.B., Kizer J.R. et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study // Hypertension. - 2007. - Vol. 50. - P. 197-203.
  34. Roman M.J., Devereux R.B., Kizer J.R. et al. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study // J. Am. Coll. Cardiol. - 2009. - Vol. 54. - P. 1730-1734.
  35. Safar M., Levy B. The response of large arteries to antihypertensive treatment. In: O’Rourke M., Safar M., Dzau V. Pharmacological Aspects in Arterial Vasodilation. - Philadelphia, PA: Lea & Febiger, 1993. - P. 157-166.
  36. Savić V., Eržen B., Janić M. et al. Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients // Diabetes & Vascular Disease Research. - 2013. - doi: 10.1177/1479164113485102.
  37. Westerhof N., Westerhof B.E. A review of methods to determine the functional arterial parameters stiffness and resistance // J. Hypertens. - 2013. - Vol. 31, N 9. - P. 1769-1775.
  38. Williams B., Lacy P.S. Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) Study: CAFE-Heart Rate // J. Am. Coll. Cardiol. - 2009. - Vol. 54. - P. 705-713.
  39. Williams B. Evaluating interventions to reduce central aortic pressure, arterial stiffness and morbidity-mortality // J. Hypertens. - 2012. - Vol. 30. - Р. 13-18.

© 2014 Zagidullin N.S., Zulkarneev R.K., Scherbakova E.S., Safina Y.F., Zagidullin S.Z.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies